SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-17-002587
Filing Date
2017-03-20
Accepted
2017-03-20 06:05:18
Documents
1
Period of Report
2017-03-10

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 3360
  Complete submission text file 0001493152-17-002587.txt   4989
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Issuer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address MONTE PELVOUX 130 FLOOR 3 MEXICO O5 11000
Business Address
Odabachian Manuel Cosme (Reporting) CIK: 0001700627 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52218 | Film No.: 17700013